Pfizer names Jeffrey Kindler new CEO

By Elaine Rigoli

Tampa, Fla., July 28 - The Pfizer board of directors has named Jeffrey B. Kindler as chief executive officer, succeeding Hank McKinnell, who will remain Pfizer's chairman of the board until his retirement in February.

Pfizer also said Kindler has been elected to the Pfizer board of directors.

Kindler, who joined the company in 2002, currently serves as Pfizer's vice chairman and general counsel.

He is responsible for many of the company's major corporate functions, including worldwide legal affairs, corporate and regulatory compliance, government relations, corporate communications, public policy development, corporate citizenship, global security and philanthropy.

Pfizer is a global pharmaceutical company based in New York.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.